- Tapinarof Cream 1% May Be Treatment Option for Psoriasis, Atopic Dermatitis
- Anti-IL-17 Antibody Treatment Not Significantly Effective for Acne
- AAP Releases “Choosing Wisely” Recommendations for Pediatric Emergency Medicine
- Polybrominated Diphenyl Ether Exposure In Utero May Increase Anxiety Risk
- Overactive Bladder Common in Postacute COVID-19 Syndrome
- Outcomes Examined for Cannabis Users After Lower-Extremity Bypass
- Cannabis Use Among Pregnant Women More Likely With Legalization
- PTSD, Psychiatric Disorders Associated With Higher Risk for Severe COVID-19 Outcomes
- Does Tralokinumab Treatment in Atopic Dermatitis Effect COVID-19 and Vaccination?
- Ruxolitinib Treatment for Atopic Dermatitis May Improve Work Productivity
- Freshwater Fish Diet Improves Liver Steatosis in NAFLD
- FDA Pulls Authorization for Bebtelovimab Due to Nonsusceptible SARS-CoV-2 Variants
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
COVID-19 Vaccination Should Not Interrupt ICI Therapy, Researchers Say
Immune Responses to SARS-CoV-2 mRNA Vaccines Vary Among Patients With Hematologic Malignancies
Efficacy of COVID-19 Booster Reduces With Methotrexate in Older Patients With RA
Homeopathic Add-On Improves QOL, Survival in Non-Small Cell Lung Cancer
Molnupiravir May Be Effective Against COVID-19 in Vaccinated, Unvaccinated Adults
